University of Zurich-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013600
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Zurich (UZH) is an educational and research university that provides bachelor, master and doctorate programs. The university offers courses in the areas of theology, law, business, economics and informatics, medicine, veterinary medicine, arts and social sciences. Its research activities include national, academic, clinical and faculty priorities. UZH provides libraries which include main library university of Zurich and Zurich central library. The university also offers counseling centers for students, study and course selection. It works in cooperation with national and international committees and organizations including League of European Research Universities, European University Association, and International Association of Universities, among others. UZH is headquartered in Zurich, Switzerland.

University of Zurich – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Zurich, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Zurich, Medical Devices Deals, 2011 to YTD 2017 9
University of Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Zurich, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich 11
Licensing Agreements 13
The Geneva Biotech Enters into Licensing Agreement with University of Zurich 13
Viventia Bio Enters into Licensing Agreement with University of Zurich 14
Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 15
Neuway Pharma Enters into Licensing Agreement with University of Zurich 16
Mirna Therapeutics Enters into Licensing Agreement with University of Zurich 17
University of Zurich – Key Competitors 18
University of Zurich – Key Employees 19
University of Zurich – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Recent Developments 21
Government and Public Interest 21
May 30, 2017: Better treatment for kidney cancer thanks to new mouse model 21
Apr 04, 2017: Common antibiotic may help to prevent or treat PTSD 22
Jun 03, 2016: Promising treatment prospects for invasive breast cancer 23
Apr 18, 2016: Psilocybin reduces psychological pain after social exclusion 24
Apr 14, 2016: Wayne State receives $2.5 million NIH grant to shape next generation of antibiotics 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
University of Zurich, Pharmaceuticals & Healthcare, Key Facts 2
University of Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Zurich, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Zurich, Deals By Therapy Area, 2011 to YTD 2017 8
University of Zurich, Medical Devices Deals, 2011 to YTD 2017 9
University of Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich 11
The Geneva Biotech Enters into Licensing Agreement with University of Zurich 13
Viventia Bio Enters into Licensing Agreement with University of Zurich 14
Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 15
Neuway Pharma Enters into Licensing Agreement with University of Zurich 16
Mirna Therapeutics Enters into Licensing Agreement with University of Zurich 17
University of Zurich, Key Competitors 18
University of Zurich, Key Employees 19
University of Zurich, Subsidiaries 20
University of Zurich, Joint Venture 20

★海外企業調査レポート[University of Zurich-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ProPhotonix Limited (PPIX):企業の財務・戦略的SWOT分析
    ProPhotonix Limited (PPIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Eni S.p.A:企業の戦略・SWOT・財務情報
    Eni S.p.A - Strategy, SWOT and Corporate Finance Report Summary Eni S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Acciona SA:戦略・SWOT・企業財務分析
    Acciona SA - Strategy, SWOT and Corporate Finance Report Summary Acciona SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Strategic Energy Resources Ltd (SER):石油・ガス:M&Aディール及び事業提携情報
    Summary Strategic Energy Resources Ltd (SER) is an oil and gas exploration and production company that acquires, explores, develops, and produces land prospective for oil and gas, graphite and mineral properties. The company operates its oil and gas projects in Gippsland basin in offshore Victoria. …
  • Sumitomo Realty & Development Co., Ltd.
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Italian Coffee Holdings Ltd:企業の戦略・SWOT・財務分析
    Italian Coffee Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Italian Coffee Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Booster Juice Ltd:企業の戦略・SWOT・財務情報
    Booster Juice Ltd - Strategy, SWOT and Corporate Finance Report Summary Booster Juice Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vietnam Enterprise Investments Limited (VEIL):企業の財務・戦略的SWOT分析
    Vietnam Enterprise Investments Limited (VEIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Navistar International Corp (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corp (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Infineum International Ltd:企業の戦略的SWOT分析
    Infineum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AC Immune SA (ACIU):製薬・医療:M&Aディール及び事業提携情報
    Summary AC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The compan …
  • Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析
    Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • K-Electric Ltd (KEL):企業の財務・戦略的SWOT分析
    K-Electric Ltd (KEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ricoh Leasing Company, Ltd.:企業の戦略・SWOT・財務情報
    Ricoh Leasing Company, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ricoh Leasing Company, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • KINeSYS Inc.:企業の戦略・SWOT・財務情報
    KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report Summary KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Akebia Therapeutics Inc (AKBA):企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Hooters of America, LLC :企業の戦略・SWOT・財務情報
    Hooters of America, LLC - Strategy, SWOT and Corporate Finance Report Summary Hooters of America, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • CK Infrastructure Holdings Ltd (1038):企業の財務・戦略的SWOT分析
    CK Infrastructure Holdings Ltd (1038) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Edcon Holdings (Proprietary) Limited:企業の戦略・SWOT・財務情報
    Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report Summary Edcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆